
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
PAREXEL International Corp. and Microsoft Corp. have announced a technology development alliance that plans to help the industry accelerate drug development and provide faster therapies to patients. By combing each companies' expertise and capabilities, this new collbaoration will drive innovation across the life sciences industry.
Read the full release






